Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
FUJIFILM Corporation (President: Kenji Sukeno) has announced the selection of Holly Springs, North Carolina as the location for its new large-scale...
FUJIFILM Diosynth Biotechnologies, en international førende organisation til kontraktudvikling og produktion (CDMO) inden for biologiske stoffer,...
FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, viral vaccines and viral ...
FUJIFILM Corporation (COO: Kenji Sukeno) and the Center for Advanced Biological Innovation and Manufacturing (CABIM), today announced that it has...
FUJIFILM Corporation (President: Kenji Sukeno) is making an investment of more than 200 Billion yen (2 Billion USD) to establish a new large-scale...
FUJIFILM Corporation (President: Kenji Sukeno) will make a major capital investment of approximately 4 billion yen ($40 million) in FUJIFILM Diosynth ...
FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, viral vaccines and gene...
Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, and FUJIFILM...
FUJIFILM Corporation (koncerndirektør Kenji Sukeno) planlægger en signifikant kapitalinvestering på ca. EUR 807 mio. i FUJIFILM Diosynth...
FUJIFILM Corporation (President: Kenji Sukeno) will make a major capital investment of approximately 100 billion yen (807 million EUR) in the Denmark ...
FUJIFILM Corporation (President: Kenji Sukeno) will make a major capital investment of approximately 100 billion yen (928 million USD) in the Denmark ...
FUJIFILM Diosynth Biotechnologies, der er en ledende virksomhed inden for kontraktudvikling og produktion af biologiske lægemidler (Contract...
FUJIFILM Diosynth Biotechnologies, a world leading biologics-Contract Development and Manufacturing Organization (CDMO), today announced that it will ...
FUJIFILM Diosynth Biotechnologies (FDB), a world leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting its partners in...
FUJIFILM Corporation announced today that it will invest approximately 9 billion yen ($83M USD) to expand the microbial production capacity of...
FUJIFILM Diosynth Biotechnologies U.S.A., Inc. (FDB), a world leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting its...
FUJIFILM Diosynth Biotechnologies U.S.A., Inc. (FDB), a Biologics Contract Development and Manufacturing Organization with experience focused on the...
FUJIFILM Diosynth Biotechnologies (FDB), a leading global biologics Contract Development and Manufacturing Organization (CDMO), placed ninth in the...
FUJIFILM Diosynth Biotechnologies (FDB), a leading global biologics and gene therapy Contract Development and Manufacturing Organization (CDMO) has...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.